Craig A. Tooman
2017 - Aratana Therapeutics
In 2017, Craig A. Tooman earned a total compensation of $950.3K as Chief Financial Officer at Aratana Therapeutics, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $95,100 |
|---|---|
| Option Awards | $238,970 |
| Salary | $360,000 |
| Stock Awards | $245,412 |
| Other | $10,800 |
| Total | $950,282 |
Tooman received $360K in salary, accounting for 38% of the total pay in 2017.
Tooman also received $95.1K in non-equity incentive plan, $239K in option awards, $245.4K in stock awards and $10.8K in other compensation.
Rankings
In 2017, Craig A. Tooman's compensation ranked 9,207th out of 14,666 executives tracked by ExecPay. In other words, Tooman earned more than 37.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,207 out of 14,666 | 37th |
Division Manufacturing | 3,542 out of 5,772 | 39th |
Major group Chemicals And Allied Products | 1,215 out of 2,075 | 41st |
Industry group Drugs | 976 out of 1,731 | 44th |
Industry Pharmaceutical Preparations | 767 out of 1,333 | 43rd |
Source: SEC filing on June 8, 2018.
Tooman's colleagues
We found three more compensation records of executives who worked with Craig A. Tooman at Aratana Therapeutics in 2017.